Park Medi World IPO
Open Date
10 Dec 2025
Close Date
12 Dec 2025
Open Date
10 Dec 2025
Close Date
12 Dec 2025
Min Investment
Lot Size
Issue Size
Price Range
Subscribed

Founded In
2011
CEO
Dr. Ajit Gupta
Utilisation of Proceeds
| Purpose | Amount |
|---|---|
| The company proposes to utilize Net Proceeds towards repayment/prepayment, in full or in part, of certain outstanding borrowings availed by the company and certain subsidiaries. This will help reduce outstanding indebtedness, assist in maintaining favorable debt-equity ratio, and reduce interest outflow. | 380 |
| The company intends to invest in subsidiaries Park Medicity NCR and Blue Heavens to fund capital expenditure requirements for construction of new hospital building in Rohtak and expansion of existing hospital in Ambala respectively. | 61 |
| The company plans to acquire advanced and diverse medical equipment for hospitals operated by the company and certain subsidiaries Blue Heavens and Ratangiri. This includes equipment for hospitals in West Delhi, Panchkula, Gorakhpur, Ambala and Jaipur. | 28 |
| The company proposes to deploy balance Net Proceeds towards unidentified inorganic acquisitions and general corporate purposes. The amount for general corporate purposes and unidentified inorganic acquisition shall not exceed certain percentage of Gross Proceeds as per regulations. | - |

- Second largest chain of private hospitals in North India and largest private hospital chain in Haryana: The company is the second largest private hospital chain in North India with 3,000 beds and largest in Haryana with 1,600 beds as of September 30, 2024. The company has grown from 1,875 beds as of April 1, 2021 to 3,000 beds through organic growth and acquisitions.
- Delivering high-quality and affordable healthcare with a diverse specialty mix: The company offers over 30 super specialty services with restated profit after tax of ₹ 1,128.90 million for six months ended September 30, 2024. The company has deployed advanced robotics system iMARS at three hospitals for minimally invasive procedures.
- Track record of successfully acquiring and integrating hospitals: The company has completed acquisition of seven hospitals adding 1,650 beds to network. Acquired hospitals contributed 54.24% of revenue from operations, 47.32% of EBITDA and 56.30% of restated profit after tax in six months ended September 30, 2024.
- Strong operational and financial performance with diversified payor mix: The company reported second highest EBITDA Margin among peers in Fiscal 2024 and second lowest gross block per bed of ₹ 3.17 million compared to peer average of ₹ 8.97 million as of March 31, 2024.
- Doctor led professional management team with industry experience: The company is led by founder Dr. Ajit Gupta with over 25 years experience and Managing Director Dr. Ankit Gupta with over 20 years experience. The team includes 891 doctors and 1,912 nurses as of September 30, 2024.


